SPOTLIGHT: Up to 100,000 Vioxx claims expected

A federal judge in New Orleans told a gathering of attorneys that there could be as many as 100,000 Vioxx claims when all is said and done. More than 2,000 cases have been filed so far and analysts have pegged Merck's potential liability at about $18 billion. Story

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.